Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOte Ads Regulatory News (OTES)

Share Price Information for Ote Ads (OTES)

Share Price is delayed by 15 minutes
Get Live Data
10.43    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: $8.67b
OTES Live PriceLast checked at - London Stock Exchange

Intraday Ote Ads Share Chart

  • This share is an international stock.

Bond Issuance

16 Jun 2022 16:00

RNS Number : 1965P
Hellenic Telecomms Organization S A
16 June 2022
 

Announcement of Regulated Information

 

 

Athens, June 16, 2022 - Hellenic Telecommunications Organization S.A. ("OTE SA") announces that its subsidiary OTE plc, issued today a €150 million bond due June 2023. The yield was set at 0.666% per annum. The new bond was fully subscribed by Deutsche Telekom AG. 

 

The new bond was issued by OTE plc and guaranteed by ΟΤΕ SA under the existing Global Medium Term Note Programme, governed by English Law, and is not listed for trading. Settlement was executed today June 16, 2022.

 

The proceeds of the new bond will be used for the refinancing of part of the €375 million OTE plc bond, maturing in July 2022.

 

The announcement is issued as a Regulated Information, in accordance with Law 3556/2007, [article 3, par. 1 (p) and article 21] and Regulation No 596/2014 (article 17) of the European Parliament and of the Council on market abuse.

 

 

 

FOR FURTHER INFORMATION:

OTE GROUP INVESTOR RELATIONS

Τel. +30 210-6118190

E-mail: iroffice@ote.gr, sziavra@ote.gr

 

 

 

NOTE: This announcement is published in accordance with the applicable provisions of, amongst others, Regulation (EU) No 596/2014 and the Rule Book (Regulation) of the Athens Exchange.

 

This announcement is not an offer of securities for sale in the United States or any other jurisdiction where to do so would be unlawful. The notes referred to in this announcement have not been and will not be registered in any jurisdiction and neither OTE SA nor OTE PLC intends to conduct a public offering of securities in any jurisdiction. In particular, no securities of OTE SA or OTE PLC have been or will be registered under the U.S. Securities Act of 1933, as amended (the Securities Act), and the notes referred to in this announcement may not be offered, sold or delivered within the United States or to, or for the account or benefit of, U.S. persons (as defined in Regulation S under the Securities Act) except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with any applicable state securities laws.

 

The offering of the notes referred to in this announcement is not being made, directly or indirectly, to the public in the Hellenic Republic (Greece). None of this announcement and any other documents or materials relating to the notes referred to herein constitute an "offer of securities to the public" as defined in Regulation (EU) 2017/1129 (the "Prospectus Regulation"), for the purchase, sale or exchange of, or otherwise for an investment in, securities in the territory of Greece. Accordingly, neither this announcement nor any other documents or materials relating to such notes have or will be submitted to the Hellenic Capital Market Commission for approval pursuant to the Prospectus Regulation. No offer of securities will be made in Greece other than in accordance with an exemption under the Prospectus Regulation (as defined below).

 

This document is an advertisement and is not a prospectus for the purposes of the Prospectus Regulation. The Final Terms for the notes referred to herein, supplementing the Base Prospectus (dated 10 April 2019, as supplemented on 12 September 2019) will be published on the website of the Luxembourg Stock Exchange at www.bourse.lu. Investors should not subscribe for any transferable securities referred to in this document other than on the basis of information contained in the relevant Final Terms and the Base Prospectus, as supplemented.

 

This document is not being distributed to, and must not be passed on to, the general public in the United Kingdom. The communication of this document as a financial promotion is only being made to those persons falling within Article 12, Article 19(5) or Article 49 of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 or to other persons to whom this document may otherwise be distributed without contravention of section 21 of the Financial Services and Markets Act 2000, or any person to whom it may otherwise lawfully be made(all such persons being together referred to as "relevant persons"). Any investment or investment activity relating to the notes is available only to relevant persons and will be engaged in only with relevant persons. Each recipient also represents and agrees that it has complied and will comply with all applicable provisions of the Financial Services Markets Act 2000 with respect to anything done by it in relation to any notes in, from or otherwise involving the United Kingdom. The notes are not being offered to the public in the United Kingdom.

 

MIFID II product governance / High net worth retail investors, professional investors and ECPs target market - Solely for the purposes of each manufacturer's product approval process, the target market assessment in respect of the Notes has led to the conclusion that: (i) the target market for the Notes is eligible counterparties and professional clients, each as defined in Directive 2014/65/EU (as amended, "MiFID II") and retail clients (as defined in MiFID II) that are in a financial situation to be able to bear a loss of their entire investment in the Notes; (ii) all channels for distribution of the Notes to eligible counterparties and professional clients are appropriate; and (iii) the following channels for distribution of the Notes to such retail clients are appropriate - investment advice, portfolio management, non-advised sales and pure execution services - subject to the distributor's suitability and appropriateness obligations under MiFID II, as applicable. Any person subsequently offering, selling or recommending the Notes (a "distributor") should take into consideration the manufacturers' target market assessment; however, a distributor subject to MiFID II is responsible for undertaking its own target market assessment in respect of the Notes (by either adopting or refining the manufacturers' target market assessment) and determining appropriate distribution channels, subject to the distributor's suitability and appropriateness obligations under MiFID II.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUNVSRUVUNAAR
Date   Source Headline
2nd Jun 20268:11 amRNSPurchase of own shares
26th May 20267:00 amRNSPurchase of own shares
19th May 20261:00 pmRNSInvitation of Ordinary General Meeting 2026
18th May 20267:59 amRNSPurchase of own shares
11th May 20268:10 amRNSPurchase of own shares
8th May 20268:02 amRNS1st Quarter Results
5th May 20267:00 amRNSPurchase of own shares
27th Apr 20267:34 amRNSPurchase of own shares
20th Apr 20267:57 amRNSPurchase of own shares
7th Apr 20267:00 amRNSRelease date of Q1 2026 Financial Results
7th Apr 20267:00 amRNSPurchase of own shares
30th Mar 20267:54 amRNSPurchase of own shares
23rd Mar 20267:28 amRNSPurchase of own shares
16th Mar 20267:32 amRNSPurchase of Own Shares
16th Mar 20267:32 amRNSPurchase of Own Shares
9th Mar 20267:28 amRNSPurchase of own shares
27th Feb 20269:47 amRNSCommencement of 2026 Share Buyback Programme
26th Feb 20268:26 amRNSQ4 2025-FY 2025 Financial Results
29th Jan 20263:49 pmRNSAnnouncement-Completion of UFBB
26th Jan 202612:58 pmRNSFinancial Calendar 2026
23rd Jan 20262:38 pmRNSOwn shares purchase – OTE Shares Award Plan
22nd Jan 20268:14 amRNSRelease date of Q4 2025 Financial Results
12th Jan 20267:33 amRNSPurchase of own shares
5th Jan 20268:03 amRNSPurchase of own shares
29th Dec 20259:59 amRNSPurchase of own shares
29th Dec 20259:59 amRNSPurchase of own shares
19th Dec 20258:09 amRNSPurchase of own shares
19th Dec 20258:09 amRNSPurchase of own shares
18th Dec 20254:34 pmRNSAnnouncement-extraordinary dividend distribution
18th Dec 20254:34 pmRNSAnnouncement-extraordinary dividend distribution
15th Dec 20258:59 amRNSPurchase of own shares
8th Dec 20257:27 amRNSPurchase of Own Shares
4th Dec 20253:12 pmRNSAnnouncement of regulated information
2nd Dec 20252:17 pmRNSAnnouncement of regulated information
1st Dec 20258:17 amRNSPurchase of own shares
26th Nov 20251:25 pmRNSAnnouncement of regulated information
25th Nov 20252:10 pmRNSAnnouncement of regulated information
24th Nov 202512:33 pmRNSAnnouncement of regulated information
24th Nov 20257:50 amRNSPurchase of Own Shares
20th Nov 202511:35 amRNSAnnouncement of regulated information
20th Nov 202510:10 amRNSAnnouncement of regulated information
19th Nov 202510:13 amRNSAnnouncement of regulated information
19th Nov 20259:05 amRNSAnnouncement of regulated information
18th Nov 20252:47 pmRNSAnnouncement of regulated information
18th Nov 20251:52 pmRNSAnnouncement of regulated information
18th Nov 202512:44 pmRNSAnnouncement of regulated information
17th Nov 20257:59 amRNSPurchase of Own Shares
13th Nov 202510:35 amRNSUPDATE OF FINANCIAL CALENDAR 2025
13th Nov 20257:49 amRNS3rd Quarter Results
10th Nov 20258:36 amRNSPurchase of own shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.